BRUNO FARMACEUTICI SpA
Discover BRUNO FARMACEUTICI SpA: Italian pharmaceutical innovation
BRUNO FARMACEUTICI SpA is an Italian pharmaceutical company founded in 1996 by Dr. Antonio Bruno, with the aim of developing and commercializing drugs with high therapeutic value. Specializing in therapeutic areas such as cardiovascular, pain and inflammation, diabetes and obesity, osteoporosis, insomnia, infectious diseases, dependencies, and supplements, the company stands out for the innovation and effectiveness of its products.
Innovation and research at the service of health
BRUNO FARMACEUTICI SpA constantly invests in research and development, focusing on innovative and improved formulations to ensure optimal therapeutic adherence for patients. The company is a market leader in solid oral corticosteroids and antidiabetic drugs, offering advanced therapeutic solutions in various areas.
Product range and competitive advantages
Among the flagship products of BRUNO FARMACEUTICI SpA are Deltacortene, a reference systemic corticosteroid, and Glucophage, for diabetes treatment. The company has recently embarked on the development of innovative and patented dietary supplements, with the intention of expanding its activities into the nutraceutical sector, providing comprehensive solutions for patient well-being.






